Ajanta Pharma Q2 Results
- BSE: 532331
- NSE: AJANTPHARM
- ISIN: INE031B01049
- Sector: Biotechnology & Drugs
BSE
3,575.00
-1.60 (-0.04%)
-1.60 (-0.04%)Volume2.24 K
Updated: Wed 7 Oct, 2026 | 15:29:41
NSE
3,570.00-3.40 (-0.10%)
-3.40 (-0.10%)Volume93.21 K
Updated: Wed 7 Oct, 2026 | 15:29:56
Technical Trends
Long TermConsiders price movement over the last 6 months
Not Available
Short TermConsiders price movement over the last 1-2 weeks
Not Available
- Bearish
- Moderately Bearish
- Neutral
- Moderately Bullish
- Bullish
Insight: Trends unavailable at the moment.
Q2 Results Highlights
Quarter ended Sep 25
Note: Comparison is on QoQ basis
Quarterly - Ajanta Pharma Q2 Results
*All figures in crores except per share values
| Fiscal Period | Sep 25 | Jun 26 | QoQ Comp | Sep 24 | YoY Comp |
|---|---|---|---|---|---|
| Total Operating Expense | 1,027.92 | 1,216.29 | 6.25% | 884.21 | 16.25% |
| Depreciation/ Amortization | 42.97 | 44.50 | 4.07% | 34.39 | 24.95% |
| Operating Income | 325.81 | 409.67 | -2.80% | 302.43 | 7.73% |
| Net Income | 260.19 | 334.22 | 1.90% | 216.48 | 20.19% |
| Other Operating Expenses Total | 351.13 | 462.83 | 1.08% | 327.18 | 7.32% |
| Net Income Before Taxes | 340.81 | 446.80 | 2.92% | 290.24 | 17.42% |
| Total Revenue | 1,353.73 | 1,625.96 | 3.92% | 1,186.64 | 14.08% |
| Selling/ General/ Admin Expenses Total | 317.01 | 381.11 | 4.66% | 260.96 | 21.48% |
| Diluted Normalized EPS | 20.83 | 26.75 | 1.96% | 17.26 | 20.68% |
EQUITY QUICK LINKS
FROM MARKETS
Trending Stocks
✕
Wait for it…
Oops! Looks like you have exceeded the limit to bookmark the image. Remove some to bookmark this image.